Professor Nicholas Talley – Distinguished Laureate Professor Nicholas Talley AC is a Scien- tific Advisory Board member at BluMaiden Biosciences. Currently he is based at the Univer- sity of Newcastle, Australia and held former appointments as Chair of the Department of Internal Medicine at Mayo Clinic in Jacksonville, Florida, a Professor of Medicine and Professor of Epidemiology at Mayo Clinic and Foundation Professor of Medicine at the University of Sydney, Nepean Hospital.
Professor Talley is considered one of the world’s leading authorities in diseases of the upper and lower gastrointestinal tract. Among other advances, his research has document- ed genetic determinants of irritable bowel syndrome (IBS), and the role of the immune system and gut microbiota in functional gastrointestinal disease. At BluMaiden Biosciences, he is guiding the scientific team as they develop pioneering solutions to human microbiome associated diseases.
About BluMaiden Biosciences BluMaiden Biosciences is an early-stage biotechnology company headquartered in Singapore with the goal of developing microbiome-derived molecular therapeutics for patients with unmet medical needs. We have integrated a unique computational population-scale data acquisition platform with a therapeutics discovery platform.
Contact Information BluMaiden Biociences Pte Ltd